Jie Luan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jie Luan has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Shangshan Li
Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
17 shared publicationsSu Fu
Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
16 shared publicationsDali Mu
Breast Plastic and Reconstructive Surgery Center of Plastic Surgery Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Shijingshan, China
9 shared publicationsYue Liu
Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
9 shared publicationsJun Qi
Breast Plastic and Reconstructive Surgery Center of Plastic Surgery Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China
8 shared publicationsWenyue Liu
Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
8 shared publications
Latest Publications
- 7 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (12) , 4684-4696
Endoscopic Transaxillary High Dual-Plane Augmentation with Inframammary Fold Lowering: Feasibility and Limitations in the Correction of Breast Ptosis
Background The correction of breast ptosis using implants alone remains controversial. Given the preference for transaxillary approaches among Asian women, we developed a novel technique: endoscopic-assisted transaxillary high dual-plane breast augmentation combined with moderate lowering of the inframammary fold (IMF). This study aimed to investigate its feasibility and limitations. Methods We retrospectively analyzed patients with varying degrees of breast ptosis who underwent implant-based augmentation between January 2023 and January 2024 using this technique. Data collected included patient demographics, ptosis grade, implant parameters, preoperative and 12-month postoperative breast measurements, and satisfaction scores. Receiver operating characteristic (ROC) curve analysis was performed to identify optimal preoperative thresholds for predicting surgical satisfaction. Results A total of 48 breasts from 24 women were included: 41 with pseudoptosis, 5 with mild ptosis, and 2 with moderate ptosis. At 12 months postoperatively, the vertical distances from the sternal notch to the IMF, to the inferior boundary of the breast contour (IBBC), and from the nipple to the IMF, as well as nipple-to-IMF surface and maximum stretch distances, significantly increased (P < 0.001). The IBBC-to-IMF vertical distance significantly decreased (P < 0.001). Overall satisfaction was 66.67% (70.73% for pseudoptosis, 60% for mild ptosis); all moderate ptosis cases were unsatisfactory. ROC analysis identified optimal preoperative thresholds: 1.80 cm for the nipple-to-IMF vertical distance, 0.95 cm for the IBBC to IMF, and 5.75 cm for the nipple-to-IMF surface distance. Conclusions With proper patient selection, this technique can be effectively applied to improve pseudoptosis and possibly mild breast ptosis, but is not recommended for moderate ptosis. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 7 January 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (12) , 4684-4696
Endoscopic Transaxillary High Dual-Plane Augmentation with Inframammary Fold Lowering: Feasibility and Limitations in the Correction of Breast Ptosis
Background The correction of breast ptosis using implants alone remains controversial. Given the preference for transaxillary approaches among Asian women, we developed a novel technique: endoscopic-assisted transaxillary high dual-plane breast augmentation combined with moderate lowering of the inframammary fold (IMF). This study aimed to investigate its feasibility and limitations. Methods We retrospectively analyzed patients with varying degrees of breast ptosis who underwent implant-based augmentation between January 2023 and January 2024 using this technique. Data collected included patient demographics, ptosis grade, implant parameters, preoperative and 12-month postoperative breast measurements, and satisfaction scores. Receiver operating characteristic (ROC) curve analysis was performed to identify optimal preoperative thresholds for predicting surgical satisfaction. Results A total of 48 breasts from 24 women were included: 41 with pseudoptosis, 5 with mild ptosis, and 2 with moderate ptosis. At 12 months postoperatively, the vertical distances from the sternal notch to the IMF, to the inferior boundary of the breast contour (IBBC), and from the nipple to the IMF, as well as nipple-to-IMF surface and maximum stretch distances, significantly increased (P < 0.001). The IBBC-to-IMF vertical distance significantly decreased (P < 0.001). Overall satisfaction was 66.67% (70.73% for pseudoptosis, 60% for mild ptosis); all moderate ptosis cases were unsatisfactory. ROC analysis identified optimal preoperative thresholds: 1.80 cm for the nipple-to-IMF vertical distance, 0.95 cm for the IBBC to IMF, and 5.75 cm for the nipple-to-IMF surface distance. Conclusions With proper patient selection, this technique can be effectively applied to improve pseudoptosis and possibly mild breast ptosis, but is not recommended for moderate ptosis. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 15 December 2025
- Published by Springer Nature in Cytotechnology
- Vol. 78 (1) , 19
Optimal cell concentration for cryopreservation of banked human adipose tissue-derived stem cells
Human adipose tissue-derived stem cells (hADSCs) are an attractive source for regenerative medicine. However, cryopreservation protocols—particularly with respect to optimal cell concentration—remain inadequately defined. hADSCs were isolated from adipose tissue of 12 donors (mean age: 31.8 ± 8.9 years; BMI: 22.9 ± 4.2). Second-passage cells were cryopreserved for two weeks at concentrations of 0.5 × 10⁶/mL, 1 × 10⁶/mL, 2 × 10⁶/mL, 5 × 10⁶/mL, and 10 × 10⁶/mL. Post-thaw viability, apoptosis, immunophenotype, proliferation, and tri-lineage differentiation were evaluated using standard assays. Cell viability increased significantly with higher cryopreservation concentrations, reaching 94.2 ± 2.0% at 10 × 10⁶/mL (p < 0.05 vs. 0.5 × 10⁶/mL). Early apoptosis decreased with increasing concentration, reaching its lowest level at 5 × 10⁶/mL (2.9 ± 0.5%; p < 0.05 vs. 10 × 10⁶/mL), but showed a slight increase at 10 × 10⁶/mL. Proliferation and tri-lineage differentiation into adipocytes, osteoblasts, and chondrocytes were maintained across all groups, as confirmed by histological staining and molecular analyses. Cryopreservation at 5 × 10⁶/mL offers the most favorable balance between high viability and minimal apoptosis while preserving proliferative and differentiation potential. This concentration likely represents an optimal condition for hADSC biobanking and clinical use.
- 15 December 2025
- Published by Springer Nature in Cytotechnology
- Vol. 78 (1) , 19
Optimal cell concentration for cryopreservation of banked human adipose tissue-derived stem cells
Human adipose tissue-derived stem cells (hADSCs) are an attractive source for regenerative medicine. However, cryopreservation protocols—particularly with respect to optimal cell concentration—remain inadequately defined. hADSCs were isolated from adipose tissue of 12 donors (mean age: 31.8 ± 8.9 years; BMI: 22.9 ± 4.2). Second-passage cells were cryopreserved for two weeks at concentrations of 0.5 × 10⁶/mL, 1 × 10⁶/mL, 2 × 10⁶/mL, 5 × 10⁶/mL, and 10 × 10⁶/mL. Post-thaw viability, apoptosis, immunophenotype, proliferation, and tri-lineage differentiation were evaluated using standard assays. Cell viability increased significantly with higher cryopreservation concentrations, reaching 94.2 ± 2.0% at 10 × 10⁶/mL (p < 0.05 vs. 0.5 × 10⁶/mL). Early apoptosis decreased with increasing concentration, reaching its lowest level at 5 × 10⁶/mL (2.9 ± 0.5%; p < 0.05 vs. 10 × 10⁶/mL), but showed a slight increase at 10 × 10⁶/mL. Proliferation and tri-lineage differentiation into adipocytes, osteoblasts, and chondrocytes were maintained across all groups, as confirmed by histological staining and molecular analyses. Cryopreservation at 5 × 10⁶/mL offers the most favorable balance between high viability and minimal apoptosis while preserving proliferative and differentiation potential. This concentration likely represents an optimal condition for hADSC biobanking and clinical use.
- 5 December 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (7) , 2524-2532
A Two-Dimensional Quantitative Assessment Method for Breast Ptosis Following Transaxillary Implant Augmentation
Background Implant-only augmentation is generally considered to have limited effect in correcting breast ptosis, and standardized selection criteria are lacking. Traditional grading focuses mainly on nipple–inframammary fold (IMF) position, overlooking the inferior breast border (IBB)’s relation to the IMF. This study proposes and validates a two-dimensional quantitative assessment method—Nipple Ptosis Score (NPS) and Inferior Breast Border Ptosis Score (IBPS)—to evaluate ptosis and predict satisfaction after transaxillary implant-only augmentation. Methods We retrospectively analyzed patients undergoing transaxillary implant-only augmentation between June 2023 and June 2024. Preoperative and 12-month postoperative NPS and IBPS were measured. Patient satisfaction at 12 months was recorded. Correlation analysis, receiver operating characteristic (ROC) curves, and one-way ANOVA were used to assess validity, predictive accuracy, and associations with satisfaction. Results Twenty-five patients (50 breasts) were included. The method demonstrated good construct and external validity. ROC-derived cutoff scores were IBPS ≤ 1.5 (area under the curve [AUC] = 0.839) and NPS ≤ 2.5 (AUC = 0.710). ANOVA indicated that breasts meeting both thresholds achieved the highest postoperative satisfaction, whereas those meeting neither had the lowest (p < 0.001). Meeting only the IBPS threshold showed a trend toward higher satisfaction than meeting only the NPS threshold (p = 0.050). Conclusions The two-dimensional quantitative assessment method provides an objective evaluation of breast ptosis. In Chinese women meeting implant volume requirements, preoperative IBPS ≤ 1.5 and NPS ≤ 2.5 predict higher satisfaction after transaxillary implant-only augmentation. IBPS shows stronger predictive potential for patient selection and surgical planning. Level of Evidence I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 5 December 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (7) , 2524-2532
A Two-Dimensional Quantitative Assessment Method for Breast Ptosis Following Transaxillary Implant Augmentation
Background Implant-only augmentation is generally considered to have limited effect in correcting breast ptosis, and standardized selection criteria are lacking. Traditional grading focuses mainly on nipple–inframammary fold (IMF) position, overlooking the inferior breast border (IBB)’s relation to the IMF. This study proposes and validates a two-dimensional quantitative assessment method—Nipple Ptosis Score (NPS) and Inferior Breast Border Ptosis Score (IBPS)—to evaluate ptosis and predict satisfaction after transaxillary implant-only augmentation. Methods We retrospectively analyzed patients undergoing transaxillary implant-only augmentation between June 2023 and June 2024. Preoperative and 12-month postoperative NPS and IBPS were measured. Patient satisfaction at 12 months was recorded. Correlation analysis, receiver operating characteristic (ROC) curves, and one-way ANOVA were used to assess validity, predictive accuracy, and associations with satisfaction. Results Twenty-five patients (50 breasts) were included. The method demonstrated good construct and external validity. ROC-derived cutoff scores were IBPS ≤ 1.5 (area under the curve [AUC] = 0.839) and NPS ≤ 2.5 (AUC = 0.710). ANOVA indicated that breasts meeting both thresholds achieved the highest postoperative satisfaction, whereas those meeting neither had the lowest (p < 0.001). Meeting only the IBPS threshold showed a trend toward higher satisfaction than meeting only the NPS threshold (p = 0.050). Conclusions The two-dimensional quantitative assessment method provides an objective evaluation of breast ptosis. In Chinese women meeting implant volume requirements, preoperative IBPS ≤ 1.5 and NPS ≤ 2.5 predict higher satisfaction after transaxillary implant-only augmentation. IBPS shows stronger predictive potential for patient selection and surgical planning. Level of Evidence I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 16 December 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (7) , 1973-1987
The Influencing Factors of Breast Morphological Changes After Dual-Plane Augmentation with Smooth Round Implans: A Correlational Study
Background Breast morphology is the primary objective indicator for evaluating the outcome of augmentation surgery. Studies have indicated that breast morphology undergoes certain changes during the early postoperative period, which may result in a discrepancy between postoperative outcomes and preoperative design. This study utilized three-dimensional scanning technology and statistical methods to analyze the influencing factors of breast morphology changes, aiming to provide reference for implant selection and preoperative surgical planning. Methods The study included patients who underwent endoscopic-assisted transaxillary dual-plane augmentation from July 2020 to June 2022. Anthropometry and three-dimensional scanning were performed on the enrolled patients, and the change values of postoperative breast morphological parameters were calculated. Spearman rank correlation tests were performed to assess the correlation between these changes and implant parameters as well as anthropometric measurements. Factors with high correlation were selected, and multivariate linear regression analysis was conducted. Results A total of 30 patients (60 breasts) were enrolled. The average downward displacement of the inframammary fold was 0.4 ± 0.3 cm, and the average outward displacement of the medial breast border was 0.2 ± 0.1 cm, both highly positively correlated with implant volume. The length of nipple-medial breast border increased by 0.5 ± 0.3 cm, highly positively correlated with the stretchability of the medial pole. The length of the nipple-to-inframammary fold increased by 0.6 ± 0.3 cm, highly positively correlated with implant volume and stretchability of the lower pole. Nipple displacement was 0.3 ± 0.2 cm outward, highly positively correlated with the stretchability of the medial pole. Nipple elevation was 0.2 ± 0.2 cm, highly positively correlated with implant volume and stretchability of the lower pole. Breast projection decreased by 0.4 ± 0.2 cm, highly positively correlated with preoperative breast projection. The average reduction in breast volume was 25.6 ± 15.7 cc, with the reduction value highly positively correlated with preoperative breast volume. Conclusions After smooth round implant augmentation mammoplasty, the breasts experienced slight downward and outward displacement, with the main influencing factor being the implant volume. Nipple displacement outward and upward, as well as lateral displacement, was primarily influenced by the stretchability of the medial pole. Upward displacement was mainly influenced by implant volume and the stretchability of the lower pole. The increase in length of the nipple-to-inframammary fold skin was most significantly influenced by implant volume and the stretchability of the lower pole. Breast convexity and volume gradually decreased, with preoperative breast size having the most significant impact on these changes. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 16 December 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (7) , 1973-1987
The Influencing Factors of Breast Morphological Changes After Dual-Plane Augmentation with Smooth Round Implans: A Correlational Study
Background Breast morphology is the primary objective indicator for evaluating the outcome of augmentation surgery. Studies have indicated that breast morphology undergoes certain changes during the early postoperative period, which may result in a discrepancy between postoperative outcomes and preoperative design. This study utilized three-dimensional scanning technology and statistical methods to analyze the influencing factors of breast morphology changes, aiming to provide reference for implant selection and preoperative surgical planning. Methods The study included patients who underwent endoscopic-assisted transaxillary dual-plane augmentation from July 2020 to June 2022. Anthropometry and three-dimensional scanning were performed on the enrolled patients, and the change values of postoperative breast morphological parameters were calculated. Spearman rank correlation tests were performed to assess the correlation between these changes and implant parameters as well as anthropometric measurements. Factors with high correlation were selected, and multivariate linear regression analysis was conducted. Results A total of 30 patients (60 breasts) were enrolled. The average downward displacement of the inframammary fold was 0.4 ± 0.3 cm, and the average outward displacement of the medial breast border was 0.2 ± 0.1 cm, both highly positively correlated with implant volume. The length of nipple-medial breast border increased by 0.5 ± 0.3 cm, highly positively correlated with the stretchability of the medial pole. The length of the nipple-to-inframammary fold increased by 0.6 ± 0.3 cm, highly positively correlated with implant volume and stretchability of the lower pole. Nipple displacement was 0.3 ± 0.2 cm outward, highly positively correlated with the stretchability of the medial pole. Nipple elevation was 0.2 ± 0.2 cm, highly positively correlated with implant volume and stretchability of the lower pole. Breast projection decreased by 0.4 ± 0.2 cm, highly positively correlated with preoperative breast projection. The average reduction in breast volume was 25.6 ± 15.7 cc, with the reduction value highly positively correlated with preoperative breast volume. Conclusions After smooth round implant augmentation mammoplasty, the breasts experienced slight downward and outward displacement, with the main influencing factor being the implant volume. Nipple displacement outward and upward, as well as lateral displacement, was primarily influenced by the stretchability of the medial pole. Upward displacement was mainly influenced by implant volume and the stretchability of the lower pole. The increase in length of the nipple-to-inframammary fold skin was most significantly influenced by implant volume and the stretchability of the lower pole. Breast convexity and volume gradually decreased, with preoperative breast size having the most significant impact on these changes. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 20 September 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 191, 233-243
Regenerated fat induced by a decellularized adipose matrix can survive long-term in vivo
- 20 September 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 191, 233-243
Regenerated fat induced by a decellularized adipose matrix can survive long-term in vivo
- 16 July 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (1) , 205-210
“Autologous Breast Dermal Filler”: A Novel Technique for Breast Reconstruction After Nipple- or Skin-Sparing Mastectomy in Pubertal Gigantomastia
Background For females in puberty, mastectomy caused by pathological gigantomastia usually brings significant psychological problems. Appropriate immediate breast reconstruction method is necessary. Objectives The aim of this study is to present a novel method of breast reconstruction that requires neither implants nor donor-site sacrifice. Methods All patients who were diagnosed with pathological gigantomastia and indicated for nipple-sparing or skin-sparing mastectomy (NSM or SSM) were selected. All extra skin was de-epithelialized, followed by NSM or SSM through a vertical incision on the lower pole of the breast. Then, a skin and dermal envelope in all directions was formed. Whether to preserve the nipple–areolar complex depended on its perfusion. The dermal flap was folded inward to serve as the “autologous dermal filler” and reconstruct the breast. A second surgery of inframammary fold elevation for larger projection was performed at least 6 months. Follow up for at least 1 year and record complications as well as pre- and postoperative BREAST-Q Scores. Results A total of 11 breasts were included. Four (36.4%) were NSM and seven (63.6%) were SSM. Nipple to sternal notch distance in NSM and SSM was 32.3±9.1cm and 35.1±4.4cm, respectively. No complications occurred, while one breast with NSM showed nipple upward displacement. The BREAST-Q indicated significant postoperative improvements in breast satisfaction (20.5 ± 11.3 vs 80.2 ± 10.4) and psychosocial well-being (23.4 ± 8.9 vs. 81.4 ± 11.3). Conclusions Preliminary study demonstrated the efficacy and long-term safety of “autologous breast dermal filler.” For adolescents, it is a less invasive autologous breast reconstruction method, or transitional plan for further adjustment in adulthood. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 16 July 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (1) , 205-210
“Autologous Breast Dermal Filler”: A Novel Technique for Breast Reconstruction After Nipple- or Skin-Sparing Mastectomy in Pubertal Gigantomastia
Background For females in puberty, mastectomy caused by pathological gigantomastia usually brings significant psychological problems. Appropriate immediate breast reconstruction method is necessary. Objectives The aim of this study is to present a novel method of breast reconstruction that requires neither implants nor donor-site sacrifice. Methods All patients who were diagnosed with pathological gigantomastia and indicated for nipple-sparing or skin-sparing mastectomy (NSM or SSM) were selected. All extra skin was de-epithelialized, followed by NSM or SSM through a vertical incision on the lower pole of the breast. Then, a skin and dermal envelope in all directions was formed. Whether to preserve the nipple–areolar complex depended on its perfusion. The dermal flap was folded inward to serve as the “autologous dermal filler” and reconstruct the breast. A second surgery of inframammary fold elevation for larger projection was performed at least 6 months. Follow up for at least 1 year and record complications as well as pre- and postoperative BREAST-Q Scores. Results A total of 11 breasts were included. Four (36.4%) were NSM and seven (63.6%) were SSM. Nipple to sternal notch distance in NSM and SSM was 32.3±9.1cm and 35.1±4.4cm, respectively. No complications occurred, while one breast with NSM showed nipple upward displacement. The BREAST-Q indicated significant postoperative improvements in breast satisfaction (20.5 ± 11.3 vs 80.2 ± 10.4) and psychosocial well-being (23.4 ± 8.9 vs. 81.4 ± 11.3). Conclusions Preliminary study demonstrated the efficacy and long-term safety of “autologous breast dermal filler.” For adolescents, it is a less invasive autologous breast reconstruction method, or transitional plan for further adjustment in adulthood. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 6 June 2024
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 25 (3) , 805-830
Effects of nanographene oxide on adipose-derived stem cell cryopreservation
Cryoinjury mitigation is key in cell cryopreservation. Here, we aimed to assess the effectiveness of nanographene oxide (nano-GO) for improving cryoprotectant agents (CPAs) in human adipose stem cell (hADSC) cryopreservation. For in vitro experiments, nano-GO (5 μg/mL) was added to the CPAs in the control, and passage (P) 2 hADSCs were collected and cryopreserved for around two weeks. We compared cytotoxicity, cell viability, immunophenotypes, proliferation, cell apoptosis, and tri-lineage differentiation. In vivo, studies used lipoaspirate to create non-enriched or hADSC-enriched fat tissues by combining it with PBS or hADSCs cryopreserved with the aforementioned CPAs. Each nude mouse received a 0.3 mL subcutaneous injection of the graft. At 12 weeks, the grafts were harvested. Histology, adipocyte-associated genes and protein, vascular density and angiogenic cytokines, macrophage infiltration, and inflammatory cytokines were analyzed. Nano-GO CPA contributed to increased cell viability, improved cell recovery, and lowered levels of early apoptosis. Nano GO at concentrations of 0.01–100 μg/mL caused no cytotoxicity to hADSCs. The absence of nano GOs in the intracellular compartments of the cells was confirmed by transmission electron microscopy. The fat grafts from the CPA-GO group showed more viable adipocytes and significantly increased angiogenesis compared to the PBS and CPA-C groups. Adding hADSCs from the CPA-GO group to the graft reduced macrophage infiltration and MCP-1 expression. Nano-GO plays an anti-apoptotic role in the cryopreservation of hADSCs, which could improve the survival of transplanted fat tissues, possibly via improved angiogenesis and lower inflammatory response in the transplanted adipose tissue.
- 6 June 2024
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 25 (3) , 805-830
Effects of nanographene oxide on adipose-derived stem cell cryopreservation
Cryoinjury mitigation is key in cell cryopreservation. Here, we aimed to assess the effectiveness of nanographene oxide (nano-GO) for improving cryoprotectant agents (CPAs) in human adipose stem cell (hADSC) cryopreservation. For in vitro experiments, nano-GO (5 μg/mL) was added to the CPAs in the control, and passage (P) 2 hADSCs were collected and cryopreserved for around two weeks. We compared cytotoxicity, cell viability, immunophenotypes, proliferation, cell apoptosis, and tri-lineage differentiation. In vivo, studies used lipoaspirate to create non-enriched or hADSC-enriched fat tissues by combining it with PBS or hADSCs cryopreserved with the aforementioned CPAs. Each nude mouse received a 0.3 mL subcutaneous injection of the graft. At 12 weeks, the grafts were harvested. Histology, adipocyte-associated genes and protein, vascular density and angiogenic cytokines, macrophage infiltration, and inflammatory cytokines were analyzed. Nano-GO CPA contributed to increased cell viability, improved cell recovery, and lowered levels of early apoptosis. Nano GO at concentrations of 0.01–100 μg/mL caused no cytotoxicity to hADSCs. The absence of nano GOs in the intracellular compartments of the cells was confirmed by transmission electron microscopy. The fat grafts from the CPA-GO group showed more viable adipocytes and significantly increased angiogenesis compared to the PBS and CPA-C groups. Adding hADSCs from the CPA-GO group to the graft reduced macrophage infiltration and MCP-1 expression. Nano-GO plays an anti-apoptotic role in the cryopreservation of hADSCs, which could improve the survival of transplanted fat tissues, possibly via improved angiogenesis and lower inflammatory response in the transplanted adipose tissue.
- Open Access
- 1 May 2024
- Published by KEAI Publishing in Genes & Diseases
- Vol. 11 (3) , 101087
Transcriptomic and machine learning analyses identify hub genes of metabolism and host immune response that are associated with the progression of breast capsular contracture
Capsular contracture is a prevalent and severe complication that affects the postoperative outcomes of patients who receive silicone breast implants. At present, prosthesis replacement is the major treatment for capsular contracture after both breast augmentation procedures and breast reconstruction following breast cancer surgery. However, the mechanism(s) underlying breast capsular contracture remains unclear. This study aimed to identify the biological features of breast capsular contracture and reveal the potential underlying mechanism using RNA sequencing. Sample tissues from 12 female patients (15 breast capsules) were divided into low capsular contracture (LCC) and high capsular contracture (HCC) groups based on the Baker grades. Subsequently, 41 lipid metabolism-related genes were identified through enrichment analysis, and three of these genes were identified as candidate genes by SVM-RFE and LASSO algorithms. We then compared the proportions of the 22 types of immune cells between the LCC and HCC groups using a CIBERSORT analysis and explored the correlation between the candidate hub features and immune cells. Notably, PRKAR2B was positively correlated with the differentially clustered immune cells, which were M1 macrophages and follicular helper T cells (area under the ROC = 0.786). In addition, the expression of PRKAR2B at the mRNA or protein level was lower in the HCC group than in the LCC group. Potential molecular mechanisms were identified based on the expression levels in the high and low PRKAR2B groups. Our findings indicate that PRKAR2B is a novel diagnostic biomarker for breast capsular contracture and might also influence the grade and progression of capsular contracture.
- 1 May 2024
- Published by KEAI Publishing in Genes & Diseases
- Vol. 11 (3) , 101087
Open AccessTranscriptomic and machine learning analyses identify hub genes of metabolism and host immune response that are associated with the progression of breast capsular contracture
Capsular contracture is a prevalent and severe complication that affects the postoperative outcomes of patients who receive silicone breast implants. At present, prosthesis replacement is the major treatment for capsular contracture after both breast augmentation procedures and breast reconstruction following breast cancer surgery. However, the mechanism(s) underlying breast capsular contracture remains unclear. This study aimed to identify the biological features of breast capsular contracture and reveal the potential underlying mechanism using RNA sequencing. Sample tissues from 12 female patients (15 breast capsules) were divided into low capsular contracture (LCC) and high capsular contracture (HCC) groups based on the Baker grades. Subsequently, 41 lipid metabolism-related genes were identified through enrichment analysis, and three of these genes were identified as candidate genes by SVM-RFE and LASSO algorithms. We then compared the proportions of the 22 types of immune cells between the LCC and HCC groups using a CIBERSORT analysis and explored the correlation between the candidate hub features and immune cells. Notably, PRKAR2B was positively correlated with the differentially clustered immune cells, which were M1 macrophages and follicular helper T cells (area under the ROC = 0.786). In addition, the expression of PRKAR2B at the mRNA or protein level was lower in the HCC group than in the LCC group. Potential molecular mechanisms were identified based on the expression levels in the high and low PRKAR2B groups. Our findings indicate that PRKAR2B is a novel diagnostic biomarker for breast capsular contracture and might also influence the grade and progression of capsular contracture.
- Open Access
- 25 January 2024
- Published by Elsevier in Materials Today Bio
- Vol. 25, 100974
Harnessing fine fibers in decellularized adipose-derived matrix for enhanced adipose regeneration
- 25 January 2024
- Published by Elsevier in Materials Today Bio
- Vol. 25, 100974
Open AccessHarnessing fine fibers in decellularized adipose-derived matrix for enhanced adipose regeneration
- 23 January 2024
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 154 (5) , 1003-1012
Novel Noninvasive Hybrid Flap Preconditioning Surpasses Surgical Delay in the Murine Model
Background: Ischemic necrosis in the distal portion of a flap is a challenging complication in plastic surgery. The authors hypothesized that a novel hybrid flap preconditioning (HFP) device combining foam-mediated external suction and nonsurgical delay can promote skin flap survival better than surgical delay. Method: Twenty-eight mice were divided into 4 groups: a control group, in which a 4 × 1.5–cm dorsal flap was made with no preconditioning; a surgical delay group, in which surgical delay occurred 7 days before flap elevation; a foam-mediated external suction (FMES) group, in which foam-mediated external suction at −100 mm Hg was used 5 hours a day for 6 days, and the flap was elevated on the seventh day; and a hybrid flap preconditioning (HFP) group, in which silicone strips were applied along the contour of the foam interface. The same negative-pressure protocol was used as in the FMES group. Seven days after flap elevation, macroscopic, histologic, and Western blot analyses were performed. Results: The flap survival rate was 46.25% (8.12%) in the control group, 68.72% (7.00%) in the surgical delay group, 57.03% (8.17%) in the FMES group, and 80.66% (3.27%) in the HFP group. Immunohistologic analysis of CD31+ cells in the distal end of viable tissue procured 7 days after flap elevation showed significantly higher angiogenesis in the surgical delay and HFP groups. Western blot results showed an increased expression of vascular endothelial growth factor in the surgical delay and HFP groups. Conclusions: The authors developed and fabricated a novel HFP device combining foam-mediated external suction and nonsurgical delay. The concept of HFP has proved to promote flap survival better than surgical delay. Clinical Relevance Statement: This study presented an innovative noninvasive method of flap preconditioning, which has been demonstrated to be superior to surgical delay in a murine model and holds promise for potential application in clinical settings.
- 23 January 2024
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 154 (5) , 1003-1012
Novel Noninvasive Hybrid Flap Preconditioning Surpasses Surgical Delay in the Murine Model
Background: Ischemic necrosis in the distal portion of a flap is a challenging complication in plastic surgery. The authors hypothesized that a novel hybrid flap preconditioning (HFP) device combining foam-mediated external suction and nonsurgical delay can promote skin flap survival better than surgical delay. Method: Twenty-eight mice were divided into 4 groups: a control group, in which a 4 × 1.5–cm dorsal flap was made with no preconditioning; a surgical delay group, in which surgical delay occurred 7 days before flap elevation; a foam-mediated external suction (FMES) group, in which foam-mediated external suction at −100 mm Hg was used 5 hours a day for 6 days, and the flap was elevated on the seventh day; and a hybrid flap preconditioning (HFP) group, in which silicone strips were applied along the contour of the foam interface. The same negative-pressure protocol was used as in the FMES group. Seven days after flap elevation, macroscopic, histologic, and Western blot analyses were performed. Results: The flap survival rate was 46.25% (8.12%) in the control group, 68.72% (7.00%) in the surgical delay group, 57.03% (8.17%) in the FMES group, and 80.66% (3.27%) in the HFP group. Immunohistologic analysis of CD31+ cells in the distal end of viable tissue procured 7 days after flap elevation showed significantly higher angiogenesis in the surgical delay and HFP groups. Western blot results showed an increased expression of vascular endothelial growth factor in the surgical delay and HFP groups. Conclusions: The authors developed and fabricated a novel HFP device combining foam-mediated external suction and nonsurgical delay. The concept of HFP has proved to promote flap survival better than surgical delay. Clinical Relevance Statement: This study presented an innovative noninvasive method of flap preconditioning, which has been demonstrated to be superior to surgical delay in a murine model and holds promise for potential application in clinical settings.